Completed Brain & Nervous System Genetics & Molecular Biology

Understanding the genes for Parkinson's disease

In plain English

AI plain-English summary

Parkinson’s disease genes are being tracked down to their exact DNA sequences, and then tested to see how they work together inside cells. Scientists already know that many Parkinson’s genes control two cellular cleanup processes: autophagy, which removes damaged proteins and cell components, and mitophagy, which specifically clears faulty mitochondria. But for many other genes linked to the disease, only their rough chromosomal location is known—not the gene itself. This project will identify those missing genes and map how all the known Parkinson’s genes connect to each other. The key question is whether the newly found genes also feed into autophagy and mitophagy, or whether they reveal entirely new biological pathways involved in the disease. If successful, this work will give researchers a complete genetic picture of what goes wrong in Parkinson’s cells. That map can then be used to build cellular assays—laboratory tests that measure whether a drug corrects the specific defect. This is fundamental science: it will not produce a treatment tomorrow. But understanding the full set of genes and pathways is a necessary step before anyone can design drugs that target the root causes of the disease, rather than just managing symptoms.

View original technical description
We now know many of the genes which cause and predispose to Parkinson's disease but for many others, we only know their chromosomal position. In this grant we seek to find these genes and work out how the function of all the genes for the disease relate to each other. We already know that many of the genes for the disease are involved in two related processes: autophagy (how the cell removes damages cell components and proteins) and mitophagy (how the cell removes damaged mitochondria). We will assess whether these new genes are in the same pathways or if there are other relevant pathways involved in the disease Finally, we will develop cellular assays for these pathways so that we can work towards developing drugs which correct the defects we have identified.

View the original record at the funder ↗

Researchers

Alexander Whitworth (Co-Investigator)Helene Plun-Favreau (Co-Investigator)John Hardy (Principal Investigator)Patrick Lewis (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

The molecular cell biology jigsaw of Parkinson's disease: bringing the pieces together
Identification of new components in Parkinson's Disease signalling pathways
Dissecting endolysosomal trafficking defects in Parkinson's disease
Identification of new Parkinson's genes playing a role in mitochondrial quality control
Determining the genetic aetiology of early onset Parkinson's disease

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.